Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an INtervention TO Increase MOBility in Older Hospitalized Medical Patients (INTOMOB): a Cluster Randomized Controlled Trial

NCT05639231 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT05639231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05639231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an INtervention TO Increase MOBility in Older Hospitalized Medical Patients (INTOMOB): a Cluster Randomized Controlled Trial
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2022
Completion date
July 18, 2025
Enrollment
383 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

functional status, hospital mobility, hospital-acquired condition, iatrogenic disease, life-space, mobility limitation, muscle atrophy or weakness, sarcopenia